Price (delayed)
$13.83
Market cap
$1.73B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.57
Enterprise value
$1.6B
Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using
There are no recent dividends present for WVE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.